Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Caution evidenceCoverage 5/5 core metricsLatest reported annual revenue changed -2.1% from the prior reported annual observation.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- Revenue contracted
Latest reported annual revenue changed -2.1% from the prior reported annual observation.
Why this surfaced
Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.
- Operating margin compressed
Operating margin changed -3.0 percentage points from the prior annual period.
Why this surfaced
Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.
- Free cash flow was negative
Latest reported free cash flow was -$119M.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.
- 2 filing risk checks flagged
Flagged areas: Solvency & liquidity.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
- Solvency & liquidity
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-09-06
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Medical Services$5.92B99.8%-2.1% yoy
- Other Operating$11.2M0.2%-12.3% yoy
Members sum to the consolidated $5.93B for this period.
- Medical Services$1.42B99.9%-7.3% yoy
- Other Operating$1.91M0.1%-34.2% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
latest fiscal year ending 2025-12-31 · among 4,122 US-listed filers · 318 in Healthcare| Metric | Value | vs all filers | vs sector |
|---|---|---|---|
Revenue latest fiscal-year revenue as filed | $5.9B | 82ndof 3,301 top third | 88thof 291 top third |
Revenue growth latest fiscal-year revenue vs the prior fiscal year | -2.1% | 24thof 3,135 bottom third | 19thof 277 bottom third |
Operating margin operating income ÷ revenue | -7.8% | 33rdof 2,819 bottom third | 48thof 280 middle third |
Net margin net income ÷ revenue | -6.6% | 33rdof 3,263 bottom third | 52ndof 290 middle third |
Free-cash-flow margin (operating cash flow − |capex|) ÷ revenue | -2.0% | 31stof 2,679 bottom third | 43rdof 261 middle third |
Return on equity net income ÷ stockholders' equity (positive equity only) | -308.8% | 3rdof 3,577 bottom third | 7thof 291 bottom third |
Stock comp ÷ revenue stock-based compensation ÷ revenue · lower is ranked higher | 0.8% | 73rdof 2,895 top third | 88thof 272 top third |
Days sales outstanding receivables ÷ revenue × 365 · lower is ranked higher | 41 days | 60thof 2,398 middle third | 80thof 266 top third |
Cash-flow accrual ratio (net income − operating cash flow) ÷ average total assets · lower is ranked higher | -19.0% | 88thof 3,577 top third | 86thof 272 top third |
Balance-sheet accrual ratio change in net operating assets ÷ average net operating assets · lower is ranked higher | -243.6% | 98thof 3,059 top third | 98thof 237 top third |
Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.
Earnings quality
latest fiscal year ending 2025-12-31 · accruals and cash conversion as filedPer fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.
Point-in-time ledger
first-reported vs latest filing · periods since 2020-01-01 · 17 changed periods| Line item | Period | First reported | Latest filing | Change | Filings |
|---|---|---|---|---|---|
| Goodwill Goodwill | balance at 2022-12-31 | $41.5M 10-K 2023-03-01 | $2.51M 10-K 2024-02-27 | -94.0% | first · latest · 5 filings carry it |
| Operating income OperatingIncomeLoss | quarter 2023-03-31 | $6.26M 10-Q 2023-05-09 | $417K 10-Q 2024-05-07 | -93.3% | first · latest |
| Intangibles IntangibleAssetsNetExcludingGoodwill | balance at 2022-12-31 | $67.7M 10-K 2023-03-01 | $18.4M 10-K 2024-02-27 | -72.7% | first · latest · 5 filings carry it |
| Operating income OperatingIncomeLoss | quarter 2023-09-30 | -$49M 10-Q 2023-11-02 | -$39.3M 10-Q 2024-11-07 | +19.8% | first · latest |
| Revenue RevenueFromContractWithCustomerExcludingAssessedTax | fiscal year 2021-12-31 | $1.83B 10-K 2022-03-03 | $1.52B 10-K 2024-02-27 | -17.0% | first · latest · 3 filings carry it |
| Operating income OperatingIncomeLoss | fiscal year 2022-12-31 | -$120M 10-K 2023-03-01 | -$105M 10-K 2025-02-25 | +12.5% | first · latest · 3 filings carry it |
| Revenue RevenueFromContractWithCustomerExcludingAssessedTax | fiscal year 2022-12-31 | $2.71B 10-K 2023-03-01 | $2.39B 10-K 2025-02-25 | -11.8% | first · latest · 3 filings carry it |
| Revenue RevenueFromContractWithCustomerExcludingAssessedTax | quarter 2023-03-31 | $1.14B 10-Q 2023-05-09 | $1.05B 10-Q 2024-05-07 | -7.2% | first · latest |
| Revenue RevenueFromContractWithCustomerExcludingAssessedTax | quarter 2023-06-30 | $1.15B 10-Q 2023-08-03 | $1.07B 10-Q 2024-08-06 | -7.0% | first · latest |
| Revenue RevenueFromContractWithCustomerExcludingAssessedTax | quarter 2023-09-30 | $1.22B 10-Q 2023-11-02 | $1.14B 10-Q 2024-11-07 | -6.5% | first · latest |
| Cash CashAndCashEquivalentsAtCarryingValue | balance at 2022-12-31 | $497M 10-K 2023-03-01 | $465M 10-K 2024-02-27 | -6.4% | first · latest · 5 filings carry it |
| Operating income OperatingIncomeLoss | fiscal year 2021-12-31 | -$394M 10-K 2022-03-03 | -$372M 10-K 2024-02-27 | +5.5% | first · latest · 3 filings carry it |
| Operating income OperatingIncomeLoss | quarter 2023-06-30 | -$29.8M 10-Q 2023-08-03 | -$29M 10-Q 2024-08-06 | +2.9% | first · latest |
| Interest expense InterestExpense | quarter 2023-03-31 | $1.53M 10-Q 2023-05-09 | $1.49M 10-Q 2024-05-07 | -2.6% | first · latest |
| Diluted shares WeightedAverageNumberOfDilutedSharesOutstanding | quarter 2024-03-31 | 413,437,000 shares 10-Q 2024-05-07 | 408,938,000 shares 10-Q 2025-05-06 | -1.1% | first · latest |
| Receivables ReceivablesNetCurrent | balance at 2022-12-31 | $498M 10-K 2023-03-01 | $492M 10-K 2024-02-27 | -1.1% | first · latest · 5 filings carry it |
| Interest expense InterestExpense | fiscal year 2022-12-31 | $4.53M 10-K 2023-03-01 | $4.48M 10-K 2024-02-27 | -0.9% | first · latest |
4 share-count periods re-presented for a stock split (1-for-25) are listed apart from restatements and not counted above.
First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.
Notes by disclosure type
Not available for AGL yet: no footnote text blocks on file for this filer in the ingested DERA files.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.